PIM
MLAB icon

Penobscot Investment Management’s Mesa Laboratories MLAB Stock Holding History

Penobscot Investment Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,010
Closed -$206K – 225
2022
Q2 		$206K Hold
1,010
– – 0.04% 220
2022
Q1 		$257K Hold
1,010
– – 0.04% 216
2021
Q4 		$331K Hold
1,010
– – 0.04% 201
2021
Q3 		$305K Hold
1,010
– – 0.05% 200
2021
Q2 		$274K Buy
+1,010
New +$256K 0.04% 208

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Penobscot Investment Management's MLAB Position: Q3 2022 in Review

Penobscot Investment Management sold out of Mesa Laboratories (MLAB) in Q3 2022, closing a stake of 1,010 shares — an estimated $206K sold.

Penobscot Investment Management first reported a position in MLAB in Q2 2021 and held it in 5 quarters. The position peaked at $331K in Q4 2021. 163 funds tracked by Wall St. Rank hold MLAB as of Q3 2022.

  • Penobscot Investment Management reported no remaining Mesa Laboratories position as of Q3 2022 after selling out during the quarter.
  • Penobscot Investment Management sold 1,010 Mesa Laboratories shares in Q3 2022, an estimated $206K.
  • Penobscot Investment Management first reported a position in Mesa Laboratories in Q2 2021 and held it in 5 quarters.
  • Penobscot Investment Management's Mesa Laboratories position peaked at $331K in Q4 2021.
  • 163 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2022.

Based on Penobscot Investment Management's 13F filing for Q3 2022, filed 2 Nov 2022.